Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05DRG
|
|||
Former ID |
DIB002500
|
|||
Drug Name |
PDC-31
|
|||
Synonyms |
PDC-31 (nasal, dysmenorrhea); PDC-31 (nasal, dysmenorrhea), PDC; THG-113 (nasal formulation, primary dysmenorrhea), PDC Biotech; THG-113.31 (nasal, primary dysmenorrhea), PDC Biotech
Click to Show/Hide
|
|||
Indication | Dysmenorrhea [ICD-11: GA34.3; ICD-9: 625.3] | Investigative | [1] | |
Company |
Theratechnologies Inc
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Prostaglandin F2-alpha receptor (PTGFR) | Target Info | Antagonist | [1] |
KEGG Pathway | Calcium signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Reactome | Prostanoid ligand receptors | |||
G alpha (q) signalling events | ||||
WikiPathways | Prostaglandin Synthesis and Regulation | |||
GPCRs, Class A Rhodopsin-like | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
Small Ligand GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
GPCRs, Other |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 344). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.